Topic

COVID-19

Fillmore has extensively examined the determinants of severe COVID-19 outcomes, with a particular focus on high-risk populations such as patients with hematologic malignancies, lung cancer, and those receiving immunosuppressive therapies. His research highlights the critical role of targeted antiviral treatments and booster vaccinations in reducing mortality among these vulnerable groups. Additionally, he has developed dynamic risk prediction tools and refined surveillance metrics to improve the identification of severe disease and the delivery of timely therapeutic interventions.

Publications (21)

2025
2023
2023
2022
2022
2020